DURVALUMAB

durvalumab 120 mg/2.4 mL injection, 2.4 mL vial

DURVALUMAB (15292W)

15292W
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required (STREAMLINED)

Restriction  18417

Indication: Urothelial carcinoma
Treatment phase: Initial treatment - neoadjuvant setting

Restriction  18482

Indication: Urothelial carcinoma
Treatment phase: Continuing treatment - adjuvant setting
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 1500 mg # of repeats: 3 DPMA: $10,853.55 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Imfinzi
(durvalumab 120 mg/2.4 mL injection, 2.4 mL vial)
Imfinzi
(durvalumab 500 mg/10 mL injection, 10 mL vial)